Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MDT
MEDTRONIC PLC
NYSE
$92.41
▲ UP 1.94% (1.75)

KEY STATISTICS

Market Cap$115.90 B
52w High$106.33
52w Low$73.31
Dividend Yield3.06%
FrequencyQuarterly
P/E16.71
Volume8.93M
Shares Out.1.28B

COMPANY

LEADERSHIP

Geoffrey Straub Martha
CHIEF EXECUTIVE
Geoffrey Straub Martha

COMPENSATION 2026

Salary$1,399,039
Stock Awards$13,672,200
Incentive Plan Pay$2,307,200
All Other Comp.$386,255
Total$22,940,252

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 2, 1973
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
95,000

PRICE TARGET

Target High$119.00
Target Low$80.00
Target Median$91.00
Target Consensus$94.85

UPCOMING EARNINGS

DateSep 1, 2026
DayTuesday
Rev. Est.$9.55B
SEP
1
TUE

SPLIT RECORD

DATETYPERATIO
1999-09-27Forward2:1
1997-09-15Forward2:1
1995-09-29Forward2:1
1994-09-30Forward2:1
1991-08-30Forward2:1
1989-08-31Forward2:1
1980-08-01Forward2:1

PRICE

$92.41 ▲ UP 1.94% (+$1.75)
OVERLAYS
$91.50$93.00$94.509:30 AM9:55 AM10:20 AM10:45 AM11:10 AM11:35 AM12:00 PM92.41

About Medtronic plc

https://www.medtronic.com ↗

Medtronic develops and sells medical devices across cardiovascular, surgical, neuroscience, and diabetes segments worldwide, including implantable devices, surgical tools, imaging systems, and glucose management solutions.

INDUSTRY

Medical - Devices

A PRODUCT MEDTRONIC PLC IS KNOWN FOR

Hugo Robotic-Assisted Surgery (RAS) System
Hugo Robotic-Assisted Surgery (RAS) System

Medtronic's modular, multi-quadrant platform for soft-tissue surgery, recently launched in the U.S., is a key growth driver advancing minimally invasive robotic surgery access.

COMPETITORS

COMPETITOR
GMED COMPARE
ISRG COMPARE
JNJ COMPARE
SYK COMPARE
ZBH COMPARE

Revenue by Products

IconPRODUCTQ4-2025Q1-2026Q3-2026Q4-2026
Cardiac and Vascular Group$3.33B $3.29B ▼$3.46B ▲$7.23B ▲
Neuroscience Group$2.62B $2.42B ▼$2.56B ▲$5.31B ▲
Medical Surgical$2.21B $2.08B ▼$2.17B ▲$4.56B ▲
Diabetes Group$728M $721M ▼$796M ▲$1.59B ▲

Revenue by Geography

MapREGIONQ4-2025Q1-2026Q3-2026Q4-2026
UNITED STATES$4.55B $16.88B ▲$17.95B ▲$36.57B ▲
Total Other Countries Excluding United States and Ireland$4.35B $4.32B ▼$4.49B ▲$9.31B ▲
IRELAND$29M $33M ▲$36M ▲$74M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
397
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.15% · 40.9M
XUS.TO
0.18% · 17.1M
SPY
0.18% · 15.7M
JEPI
0.54% · 2.7M
RSP
0.21% · 2.4M
FDL
2.44% · 2.2M
NOBL
1.56% · 2.0M
SCHX
0.17% · 1.4M
VIRS
4.59% · 939.3K
DFUV
0.46% · 800.2K
FEGE
1.46% · 402.2K
SPYI
0.18% · 227.5K
AIVL
3.36% · 158.8K
BKDV
0.61% · 132.0K
TAOZ
1.93% · 110.4K
SPUS
0.31% · 106.8K
SPXL
0.13% · 98.7K
TSPA
0.19% · 96.4K
ELCV
3.11% · 90.3K
SIXH
1.31% · 86.3K
CATH
0.54% · 80.7K
AB
ABEQ
4.53% · 56.6K
ACIO
0.21% · 56.6K
APUE
0.19% · 51.8K
SF
SFGV
0.38% · 49.6K
ASLV
1.68% · 40.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
53.00%
HOLDERS
3,238
TOP 12 OF 3,238 · RANKED BY POSITION SIZE
Vanguard Group Inc
129.0M sh · $12.39B
Blackrock, Inc.
120.5M sh · $11.58B
Blackrock Inc.
111.9M sh · $8.81B
State Street Corp
63.4M sh · $5.01B
Jpmorgan Chase & Co
53.6M sh · $5.15B
Capital Research Global Investors
41.9M sh · $3.63B
Blackrock Institutional Trust Company, N.A.
37.0M sh · $2.63B
Geode Capital Management, LLC
30.2M sh · $2.35B
Bank Of America Corp /De/
26.0M sh · $2.25B
Blackrock Fund Advisors
22.0M sh · $1.57B
Bank Of New York Mellon Corp
21.5M sh · $2.04B
Massachusetts Financial Services Co /Ma/
21.4M sh · $2.66B

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity4
Return On Assets4
Debt To Equity2
Price To Earnings2
Price To Book3
Overall Score4

TRADES BY CONGRESS

HOUSE TRADES
Kevin Hern
Kevin Hern
Sale
2026-03-20
 Julie Johnson
Julie Johnson
Sale
2025-12-18
 Rich McCormick
Rich McCormick
Purchase
2025-11-05
 Ro Khanna
Ro Khanna
Sale
2025-06-27

INSIDER TRADES

★
OFFICER: EVP, PRES MEDSURG AND AMERICAS
Marinaro Michael
Sale · 1.1K shares
2026-08-20
★
DIRECTOR, OFFICER: CHAIRMAN AND CEO
Martha Geoffrey
Purchase · 103.8K shares
2026-08-03
★
OFFICER: SVP, CHIEF HR OFFICER
Walter Matthew R.
Sale · 1.7K shares
2026-07-31
★
OFFICER: EVP & PRESIDENT, NEUROSCIENCE
Thompson Kweli
Sale · 1.7K shares
2026-07-31

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OUTPERFORM 6
NEUTRAL 4
OVERWEIGHT 3
HOLD 2
21 GRADES IN THE LAST 12 MONTHS
BTIG BUY UBS BUY TD Cowen BUY Evercore ISI Group OUTPERFORM Needham BUY Bernstein OUTPERFORM Goldman Sachs NEUTRAL Leerink Partners OUTPERFORM

SECTORS PEERS

PEERPRICE
VRTX$542.27COMPARE
BMY$66.64COMPARE
SYK$325.24COMPARE
CVS$94.00COMPARE
SNY$44.48COMPARE
MCK$890.76COMPARE
GSK$50.41COMPARE
HCA$417.94COMPARE